These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report]. Terlikowska M, Marzański M. Psychiatr Pol; 1995 Dec 01; 29(3):343-8. PubMed ID: 7652087 [Abstract] [Full Text] [Related]
14. [Neuroleptic malignant syndrome. Efficacy of bromocriptine]. Azorin JM, Bouchacourt M, Lavergne T, Giudicelli S. Presse Med; 1984 Jun 30; 13(27):1702. PubMed ID: 6146134 [No Abstract] [Full Text] [Related]
15. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?]. Peschel O, Kurtz G, Müller-Felber W, Modell S. Nervenarzt; 1994 Oct 30; 65(10):718-21. PubMed ID: 7808573 [Abstract] [Full Text] [Related]
16. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases]. Truong DD, Sczesni B, Fahn S, Gross J, Donovan K, van Bakel A, Wiley MK. Nervenarzt; 1988 Feb 30; 59(2):103-9. PubMed ID: 2896306 [No Abstract] [Full Text] [Related]
17. [Neuroleptic malignant syndrome]. Retamal P. Rev Med Chil; 1990 Jun 30; 118(6):679-85. PubMed ID: 1685596 [Abstract] [Full Text] [Related]
18. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome. Lee JW. Ann Clin Psychiatry; 2007 Jun 30; 19(1):9-16. PubMed ID: 17453656 [Abstract] [Full Text] [Related]